Aktuellt
SENASTE
In line with its new strategy, Bactiguard announces it has extended its licence partnership with BD with sales exclusivity for further markets. As a recap, Bactiguard has sharpened its strategy to focus on licencing, thus transforming from a medical devices production company to a knowledge and specialist organisation. We view the announcement as a natural and positive first step, and expect similar news regarding BIP Central Venous Catheter and BIP Endotracheal Tube.
LÄS MER
